ALPINE IMMUNE SCIENCES INC - COM (ALPN)

Historical Portfolio Holders from Q3 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 0 $0 -$2.55B 0
2024 Q1 64.6M $2.56B +$356M $39.64 178
2023 Q4 58.8M $1.12B +$244M $19.06 130
2023 Q3 45.9M $526M +$103M $11.45 88
2023 Q2 37M $380M +$26.3M $10.28 76
2023 Q1 34.7M $268M +$3.56M $7.72 59
2022 Q4 34.2M $251M -$37.5M $7.35 61
2022 Q3 39.4M $284M +$111M $7.20 63
2022 Q2 24M $204M -$6.28M $8.51 55
2022 Q1 24.7M $222M -$40.4M $8.97 56
2021 Q4 18.6M $257M +$11.4M $13.85 53
2021 Q3 15.3M $164M +$24.3M $10.67 44
2021 Q2 13.2M $119M -$42.1M $9.00 47
2021 Q1 13.7M $181M +$40.7M $10.60 46
2020 Q4 13.1M $165M +$7.23M $12.60 42
2020 Q3 12.6M $110M +$47.7M $8.79 32
2020 Q2 7.12M $69.2M -$2.05M $9.71 19
2020 Q1 8.15M $23.5M -$1.03M $2.88 15
2019 Q4 8.42M $32.3M -$1.08M $3.84 18
2019 Q3 8.7M $34.4M -$76.7K $3.96 17
2019 Q2 8.71M $36.7M -$194K $4.21 23
2019 Q1 8.74M $59.9M +$8.83M $6.86 23
2018 Q4 7.45M $27.4M -$392K $3.68 22
2018 Q3 7.58M $48M -$1.89M $6.33 22
2018 Q2 7.87M $59.6M -$106K $7.57 23
2018 Q1 7.88M $63M -$968K $8.00 27
2017 Q4 7.94M $88.9M +$967K $11.20 27
2017 Q3 7.85M $91M +$91M $11.60 23